Interesting facts
Interesting Facts about N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide
N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide is a fascinating compound that belongs to the class of imidazo-pyridine derivatives, which have garnered attention in numerous fields of research. Here are some interesting aspects of this compound:
- Pharmacological Potential: Compounds with imidazo[1,2-a]pyridine scaffolds often exhibit a variety of biological activities, making them significant in pharmaceutical research. This particular compound may offer promising pharmacological properties that can be explored for therapeutic uses.
- Structural Diversity: The structure of this compound includes a unique blend of nitrogen-containing rings, which can provide an interesting platform for modifying its properties. The presence of both imidazole and pyridine rings contributes to its potential reactivity and interaction with biological targets.
- Applications in Medicinal Chemistry: Due to its structural complexity, this compound may serve as a lead structure for the development of new drugs, particularly in the fields of oncology and neurology, where imidazo-pyridine derivatives have shown effectiveness.
- Understanding Interactions: The specific arrangement of substituents, such as the methyl and p-tolyl groups, may affect the compound's affinity for biological receptors, thus offering insights into how molecular structure influences activity.
- Interdisciplinary Relevance: Beyond pharmaceuticals, the study of this compound can also bridge into materials science, where imidazole derivatives are being investigated for their role in organic electronics and catalysis.
In summary, N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide represents a synthesis of structural elegance and biological relevance. As researchers continue to explore its potential, it could pave the way for new discoveries and applications across various scientific disciplines.
Synonyms
zolpidem
82626-48-0
Zolpidemum
Zolpidemum [Latin]
Sanval
Zolpidem civ
N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
UNII-7K383OQI23
DTXSID7045946
CHEBI:10125
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide
7K383OQI23
CHEMBL911
SL800750
SL 800750
DTXCID5025946
SL 80-0750
Zolpidem (INN)
Zolpidemum (Latin)
NCGC00095179-01
N,N,6-Trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide
ZOLPIDEM [INN]
SL-800750
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide
Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-
ZOLPIDEM CIV (USP-RS)
ZOLPIDEM CIV [USP-RS]
Zolpidem [INN:BAN]
Zolpidem (1.0 mg/mL in Methanol)
N,N,6-TRIMETHYL-2-P-TOLYL-IMIDAZO(1,2-A)PYRIDINE-3-ACETAMIDE
[3H]zolpidem
CAS-82626-48-0
Edlular
zolpidem Ambien
N,N-dimethyl-2-(6-methyl-2-(4-methylphenyl)imidazo(1,2-a)pyridin-3-yl)acetamide
Sanval (TN)
ZOLPIDEM [MI]
ZOLPIDEM [VANDF]
ZOLPIDEM [WHO-DD]
SCHEMBL80516
BSPBio_002278
BIDD:GT0785
SPECTRUM1505369
GTPL4348
GTPL4362
BDBM26266
N05CF02
HMS1922F22
BCP10205
JNB60590
Tox21_111471
MFCD00153885
STK627113
Zolpidem, >=98% (HPLC), solid
AKOS005560130
Tox21_111471_1
CCG-213403
CS-1468
DB00425
ID57819
NCGC00095179-02
NCGC00095179-03
NCGC00095179-04
NCGC00095179-05
AS-35386
HY-17441
NS00010401
C07219
D08690
AB00698471-07
AB00698471_09
Q218842
SR-01000763006
SR-01000763006-3
BRD-K44876623-001-01-1
BRD-K44876623-001-03-7
SL 800750; SL-800750; SL800750
N,N,6-Trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
6-methyl-N,N-dimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide
N,N,6-Trimethyl-2-(4-Methyl Phenyl) Imidazo [1,2-alpha] Pyridine-3-Acetamide
N,N-dimethyl-2-[(4S)-6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide #
N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[3,2-a]pyridin-3-yl]acetamide
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide; N,N,6-Trimethyl-2-p-tolylimidazol[1,2-a]pyridine-3-acetamide; SL 80-0750; SL 800750;
N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide;N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyri dine-3-acetamide;N,N,6-Trimethyl-2-p-tolylimidazol[1,2-a]pyridine-3-acetamide;SL 80-0750
Solubility of N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide (C17H20N4O)
The solubility of N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide is influenced by several factors, which are crucial for its practical applications and stability in various environments. Understanding its solubility properties allows chemists and researchers to predict its behavior in different solvents, which can be summarized as follows:
It's essential to consider that the actual solubility can only be determined through experimentation, as theoretical predictions rely heavily on the molecular characteristics and the solvent's properties. This highlights the necessity of conducting solubility tests when developing formulations involving N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide to achieve the desired outcomes.